AP

Aragon Pharmaceuticals

Acquired

San Diego, United States · Founded 2009 · $114.0M raised

Headquarters
San Diego
Founded
2009
Business Model
B2B
Total Funding
$114.0M
Last Round
$42.0M Series COct 2012
Rounds
3
Acquisition Date
Jun 2013

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Aragon Pharmaceuticals was a San Diego, California-based, privately-held pharmaceutical company founded in May 2009 by co-founders including Charles Sawyers and Howard Chang, focused on developing small-molecule therapeutics for hormone-driven cancers such as prostate and breast cancer. Its lead program, an androgen receptor antagonist for prostate cancer, grew out of research into treatment-resistant tumors. In 2013, Johnson & Johnson agreed to acquire Aragon for up to $1 billion, while Aragon's other research programs were spun off into a new company, Seragon Pharmaceuticals.

Summary

Aragon Pharmaceuticals is a Biotech company based in San Diego, United States, founded in 2009. It has raised $114.0M in total across 3 rounds, most recently a $42.0M Series C round in Oct 2012. Investors include Topspin Partners.

Funding History

AcquisitionAcquisition by Johnson & JohnsonJun 2013

Sign up to see all 4 events

Funding: Series B through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aragon Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/aragon-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/aragon-pharmaceuticals" alt="Aragon Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>